A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)
Latest Information Update: 09 May 2022
At a glance
- Drugs MK 0777 (Primary)
- Indications Generalised anxiety disorder
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 24 Dec 2014 New trial record